Wave Of Molnupiravir Generics In India Amid Early Physician Cheer

India authorizes molnupiravir for restricted emergency use in COVID-19, marking the arrival of around a dozen “affordable” generics of  Merck & Co. and Ridgeback Biotherapeutics' oral antiviral. Physicians say data are “pretty compelling” notwithstanding the narrow FDA nod.

stop covid
India clears molnupiravir generics for emergency use • Source: Alamy

India has green-lighted molnupiravir for restricted emergency use in COVID-19, paving the way for the arrival of around a dozen generic versions of Merck & Co., Inc. and Ridgeback Biotherapeutics LP ‘s oral antiviral therapy in the country.

Front-line Indian firms in the fray are upbeat about potential opportunities for molnupiravir, though much will depend on the trajectory...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia